Our singular focus is fighting humanity's worst disease, cancer.

2015 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle  
12/22/15Galil Medical Tender Offer to Acquire Perseon Corporation Expires
ARDEN HILLS, Minn. and SALT LAKE CITY, Dec. 22, 2015 /PRNewswire/ -- Galil Medical Ltd. ("Galil"), a global leader in delivering innovative cryotherapy ablation solutions, today announced the expiration of the previously announced tender offer by Galil's indirect wholly owned subsidiary Galil Merger Sub, Inc. to purchase (i) all of the outstanding publicly traded shares of Perseon Corporation (NASDAQ: PRSN; PRSNW) common stock for $1.00 per share in cash and (ii) all of the outstanding pub... 
 
11/30/15Galil Medical and Perseon Corporation Announce Tender Offer/Merger Information Call
Conference Call and Webcast Scheduled for Wednesday, December 2 at 11:00 a.m. Eastern Time/9:00 a.m. Mountain Time ARDEN HILLS, Minn. and SALT LAKE CITY, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Galil Medical ("Galil"), a global leader in delivering innovative cryotherapy ablation solutions, and Perseon Corporation (NASDAQ:PRSN) (NASDAQ:PRSNW) ("Perseon" or "The Company"), a leading provider of medical systems that utilize energy to treat cancer, today announced that management will hold a Tender Offe... 
Download PDF
10/27/15Galil Medical Enters Into Agreement to Acquire Perseon Corporation to Create Leader in Ablation Treatment for Tumors
Transaction brings scale and cost savings to create high growth, high margin market opportunity capitalizing on increased global distribution Hot and cold combination provides powerful tool kit for interventional radiologists Galil Medical to pay $1.00 per Perseon share plus consideration for warrants, representing total transaction value of approximately $10.6 million Perseon provides preliminary update for the third quarter of 2015 ARDEN HILLS, Minn. and SALT LAKE CITY,... 
Download PDF
09/15/15Perseon Announces New Data for MicroThermX(R) in the Treatment of Large Liver Metastases From Colorectal Cancer and Large Hepatocellular Carcinoma From the 2015 Congress of Italian Society of Oncological Surgery (SICO) Conference
SALT LAKE CITY, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (Nasdaq:PRSN) ("Perseon" or the "Company") today announced that data supporting the use of the company's cutting edge microwave ablation technology, MicroThermX, was presented at the 38th Congress of Italian Society of Oncological Surgery (SICO) in Naples, Italy from September 9 – 12, 2015. The data included two posters, which looked at the use of multiple antennas in the treatment of large liver metastases from colorectal ca... 
Download PDF
09/08/15Perseon to Present at Rodman & Renshaw 17th Annual Global Investment Conference
SALT LAKE CITY, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN) ("Perseon" or the "Company"), a leading provider of medical systems that utilize energy to treat cancer, today announced that management will present at the Rodman & Renshaw 17th Annual Global Investment Conference being held at The St. Regis Hotel, New York City. Clint Carnell, Chief Executive Officer, will provide an overview of Perseon and its strategy at 11:40 a.m. Eastern time on Thursday, September 10, 2015... 
Download PDF
09/01/15Perseon CFO William Barth Announces Plans to Retire
SALT LAKE CITY, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN) ("Perseon" or the "Company"), a leading provider of medical systems that utilize energy to treat cancer, today announced that Chief Financial Officer William Barth, 65, has advised the Company of his plans to retire. Perseon has initiated a CFO search and Mr. Barth will stay on board until December 31, 2015, or when a successor is identified and appointed. "Since joining us in 2012, Bill has played an invalua... 
Download PDF
08/31/15Perseon Announces the Initiation of the First Multi-Organ in vivo Ablation Zone Study for MicroThermX(R) in Laparoscopic and Open Approaches
SALT LAKE CITY, Aug. 31, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (Nasdaq:PRSN) ("Perseon" or the "Company") today announced the initiation of a multi-organ in vivo ablation zone study for its MicroThermX microwave ablation system designed to provide ablation volumes based on different antenna configurations and varying ablation times in the liver, kidney and lung. The technology evaluation, which will take place at the University of Louisville, will evaluate both laparoscopic and open s... 
Download PDF
08/19/15Perseon Launches INSPIRE 2017, a Dramatic Effort to Increase Adoption of Microwave Ablation to Fight Cancer
SALT LAKE CITY, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (Nasdaq:PRSN) ("Perseon" or the "Company"), today announced the launch of INSPIRE 2017, a new campaign which is dedicated to the growth and direction of the company over the next three years, particularly in the area of lung cancer, a disease where MicroThermX is better suited to treatment than other energy ablation products due to the system's 915 MHz frequency and synchronous wave alignment technology. INSPIRE 2017 will ... 
Download PDF
08/07/15Perseon Announces Second Quarter Fiscal Year 2015 Investor & Analyst Call
SALT LAKE CITY, Aug. 7, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN), a leading provider of medical systems that utilize energy to treat cancer, will host a conference call with a live webcast on Thursday, August 13, 2015, at 11:00 a.m. Eastern Time/9:00 a.m. Mountain Time to provide a business update and outlook for fiscal year 2015. Individuals interested in listening to the conference call may do so by visiting the "Investors" section of the Company's website at www.perseonm... 
Download PDF
08/06/15Perseon Announces Data Presented at the American Association of Physicists in Medicine Meeting Supporting the Use of Microwave Ablation
SALT LAKE CITY, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN) is pleased to announce results of data presented on Sunday, July 12 at the 57th annual American Association of Physicists in Medicine (AAPM) conference, in Anaheim, California. The oral presentation focused on evaluating microwave ablation zone variances based on changes in thermal and electrical properties of tissue. The study confirms what surgeons have known for a long time – that image-guided percutaneous ... 
Download PDF
08/04/15Perseon Announces a User Enhancement Upgrade for Energy Ablation System MicroThermX(R)
SALT LAKE CITY, Aug. 4, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN) has launched a software upgrade for its industry- leading energy ablation product MicroThermX, aimed at simplifying the customer interface and enhancing the user experience. The upgrade was made available to all MicroThermX systems in service on June 16th of this year. The software upgrade to the MicroThermX system provides: a reduction in the number of screens, ability to seamlessly continue to the next proce... 
Download PDF
07/30/15Perseon Announces Pricing of $5.2 Million Public Offering and Listing of Warrants on NASDAQ
SALT LAKE CITY, July 30, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN) (NASDAQ:PRSNW) ("Perseon" or the "Company"), a leading provider of medical systems that utilize energy to treat cancer, today announced the pricing of an underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase 11,500,000 shares of common stock, at an offering price of $0.90 per share and two warrants. The warrants have a per share exercise price of $0.99, are exercisable immedia... 
Download PDF
07/16/15Perseon Announces Fiscal Year 2015 Second Quarter Results; MicroThermX(R) Revenue Grows 117% Year-over-Year
Q2 2015 Revenues Driven Solely by the Company's MicroThermX® Business MicroThermX Revenues More than Doubled Year-over-Year Reiterates Revenue Guidance of $3.5 Million to $5.0 Million for FY 2015 SALT LAKE CITY, July 16, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN) (Perseon or the Company), a leading provider of medical systems that utilize energy to treat cancer, today announced financial results for the second quarter ended June 30, 20151. Second Quarter Hig... 
Download PDF
06/22/15Perseon Announces Reverse Stock Split Effective June 23, 2015
SALT LAKE CITY, June 22, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (Nasdaq:PRSN) ("Perseon" or the "Company"), a leading provider of medical systems that utilize energy to treat cancer, today announced that it will effect a one-for-ten reverse stock split at the opening of market trading on June 23, 2015. When the reverse stock split becomes effective, every ten (10) shares of common stock outstanding will automatically convert into one (1) share of common stock with no change in par valu... 
Download PDF
05/14/15Perseon Announces Financial Results for First Quarter Fiscal Year 2015
Thursday, May 14, 2015 7:26 am MDTDateline: Salt Lake CityPublic Company Information:NASDAQ:PRSN"I am optimistic about our ability to achieve the goals we outlined this past January."Perseon Corporation (NASDAQ:PRSN) (Perseon or the Company), a leading provider of medical systems that utilize energy to treat cancer, today announced year-to-date operational highlights and financial results for the first quarter ended March 31, 2015[1].First Quarter Highlights and CommentaryExecuting 3-year strat... 
Download PDF
05/07/15Perseon Appoints Rick Gaykowski Vice President of Regulatory, Quality & Clinical Affairs
Thursday, May 7, 2015 7:16 am MDTDateline: Salt Lake CityPublic Company Information:NASDAQ:PRSN"His high caliber of expertise and extensive relationships will be invaluable to Perseon as we continue to enhance our evidence-based approach and expand our speed of innovation within the high-growth energy ablation market."Perseon Corporation (NASDAQ:PRSN) (Perseon or the Company), a leading provider of medical systems that utilize energy to treat cancer, today announced the appointment of Rick Gayk... 
Download PDF
05/06/15Perseon’s MicroThermX® to be Featured at WCIO 2015 Interventional Oncology Forum
Wednesday, May 6, 2015 7:27 am MDTDateline: Salt Lake CityPublic Company Information:NASDAQ:PRSN"This is an important scientific peer review study of our market leading microwave ablation technology"Perseon Corporation (NASDAQ:PRSN) (Perseon or the Company), a leading provider of medical systems that utilize energy to treat cancer, today announced that an abstract featuring the use of MicroThermX® technology by radiologist Sohail G. Contractor M.D., a leading expert in the field of interve... 
Download PDF
04/28/15Perseon Appoints Peter Vitulli to Board of Directors
Tuesday, April 28, 2015 1:56 pm MDTDateline: Salt Lake CityPerseon Corporation (NASDAQ:PRSN) (Perseon or the Company), a leading provider of medical systems that utilize energy to treat cancer, today announced the appointment of Peter Vitulli to the Company’s Board of Directors effective April 23, 2015.  Mr. Vitulli, President and CEO of DNA Diagnostics Center (DDC), will serve as an independent director to Perseon.   Timothy C. McQuay, Chairman of the Board of Director... 
Download PDF
04/21/15Perseon Presents Key Microwave Ablation Findings at STM 2015
Category: Clinical Trials and ResearchTuesday, April 21, 2015 1:00 pm MDTDateline: Salt Lake City"Mark is a renowned thought leader in energy ablation and his remarks at STM 2015 demonstrate Perseon’s ongoing recognition as a leading innovator"Perseon Corporation (NASDAQ:PRSN) (Perseon or the Company), a leading provider of medical systems that utilize energy to treat cancer, today announced its participation as a presenter last week at STM 2015: The 32nd Annual Meeting of the Society for ... 
Download PDF
04/20/15Perseon Corporation Announces First Quarter Fiscal Year 2015 Conference Call
Category: Results of Operations and Corporate AnnouncementsMonday, April 20, 2015 11:35 am MDTDateline: Salt Lake CityPerseon Corporation (NASDAQ:PRSN) (Perseon of the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced plans to release its financial results for the first quarter ended March 31, 2015 before the market opens on Thursday, May 14, 2015. The Company will host a corresponding conference call with a live webcast later that day at... 
Download PDF
04/17/15Perseon Announces FDA Clearance for Specific Indication of Non-Resectable Liver Tumor Ablation
Category: Product Updates and Industry DevelopmentsFriday, April 17, 2015 10:36 am MDTDateline: Salt Lake City"This expanded indication for the MicroThermX gives hospitals and patients another option for the treatment of complicated non-resectable liver tumors using microwave ablation. The expanded clinical applications combined with the ease of use and attractive economics make the MicroThermX the leading microwave ablation product on the market today."Perseon Corporation (NASDAQ: PRSN) (Perse... 
Download PDF
04/08/15Perseon’s MicroThermX® Receives FDA Clearance for Laparoscopic Ablation Procedures
Category: Results of Operations and Corporate AnnouncementsWednesday, April 8, 2015 10:11 am MDTDateline: Salt Lake City"This new indication increases the type of cases that our technology will be used for and the opportunity to expand the use of MicroThermX in surgical oncology"Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that the company received clearance from the U.S. Food and Dr... 
Download PDF
04/06/15Perseon Appoints Brian Meltzer, M.D. as Chief Medical Officer
Category: Results of Operations and Corporate AnnouncementsMonday, April 6, 2015 10:11 am MDTDateline: Salt Lake City"Brian’s career has encompassed all aspects of healthcare services and product development – from early development to market access"Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Brian A, Meltzer, M.D. as Chief Medical Officer and Vice President of Bu... 
Download PDF
04/02/15Perseon Announces SEC Filings
Category: Results of Operations and Corporate AnnouncementsThursday, April 2, 2015 10:21 am MDTDateline: Salt Lake CityPerseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced several filings with the Securities and Exchange Commission (SEC): preliminary proxy materials requesting stockholder approval for an amendment to the Company’s Amended and Restated Certificate of Incorporation, a transiti... 
Download PDF
03/03/15Perseon Engages SunTrust Robinson Humphrey to Evaluate Strategic Options
Category: Results of Operations and Corporate AnnouncementsTuesday, March 3, 2015 10:17 am MSTDateline: Salt Lake City"We have taken definitive steps over the past few months that have positioned the company for strong future growth, and therefore we believe we have many options available to us to maximize the value of our leading microwave ablation platform"Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat canc... 
Download PDF
02/26/15Perseon Appoints Jennifer R. Hoglin Vice President of Global Marketing
Category: Results of Operations and Corporate AnnouncementsThursday, February 26, 2015 9:15 am MSTDateline: Salt Lake CityPerseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Jennifer R. Hoglin as Vice President of Global Marketing, effective February 17, 2015. Ms. Hoglin is an executive marketing professional with 20 years of experience in product, brand, and business dev... 
Download PDF
02/24/15PERSEON LAUNCHES AS A NEW LIFE SCIENCES COMPANY IN THE SILICON SLOPES OF UTAH
Perseon to Showcase its Leading Microwave Ablation Technology at 40th Annual Scientific Meeting of Society of Interventional Radiology (SIR)    Category: Results of Operations and Corporate AnnouncementsTuesday, February 24, 2015 11:53 am MSTDateline: Salt Lake City"The change of our name to Perseon, a word with multiple references to our mission and technology, succinctly represents our focus as a pure play microwave ablation company with a market leading product platform"BSD Medical Corporati... 
Download PDF
02/17/15BSD Medical Corporation Announces Appointment of Ben Beckham
Category: Results of Operations and Corporate AnnouncementsTuesday, February 17, 2015 7:20 am MSTDateline: Salt Lake City"With our new sales program launching this month, I look forward to driving aggressive and highly disciplined sales execution by the team in the months ahead and over the long term."BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Ben Beckham as Vice Pres... 
Download PDF
02/09/15BSD Medical Corporation Announces Changes to its Board of Directors
Category: Results of Operations and Corporate AnnouncementsMonday, February 9, 2015 2:06 pm MSTDateline: Salt Lake City"With our changing product focus, we are seeking new independent directors with vast life science and commercialization success"BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the resignation of Gerhard W. Sennewald, Ph.D., and Douglas P. Boyd, Ph.D., as members of the Board... 
Download PDF
01/29/15BSD Medical Corporation Provides Progress Update on Strategic Plan
Submits non-binding term sheet for hyperthermia assetsCommences monetization of real estate assetsExpects 180-day grace period extension from NASDAQCategory: Results of Operations and Corporate AnnouncementsThursday, January 29, 2015 10:50 am MSTDateline: Salt Lake City"I am comfortable with the runway we have in front of us to deliver shareholder value.  In the coming months, we intend to demonstrate progress to shareholders on our turnaround efforts, including reporting on microwave abla... 
Download PDF
01/15/15BSD Medical Corporation Reports First Quarter 2015 Financial Results
Investor & Analyst Conference Call Today at 2:00 p.m. Eastern Time/12:00 p.m. Mountain TimeCategory: Results of Operations and Corporate AnnouncementsThursday, January 15, 2015 7:20 am MSTDateline: Salt Lake CityBSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported financial results for the fiscal first quarter of 2015 ended November 30, 2014. Total revenues were $843,168 for the first quarter ... 
Download PDF
01/12/15BSD Medical Corporation Outlines Strategy and Revenue Targets for Microwave Ablation Solutions
Investor & Analyst Conference Call Scheduled for Thursday, January 15 at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time; RSVP RequiredCategory: Results of Operations and Corporate AnnouncementsMonday, January 12, 2015 7:21 am MSTDateline: Salt Lake City"Since joining BSD in November,  I have made some initial observations based on extensive meetings with customers, employees, and physicians that have informed our strategic plan for the next several years"BSD Medical Corporation (NASDA... 
Download PDF